In systemic sclerosis, current clinical descriptors do not fully explain why patients with similar serological profiles can have very different degrees of skin involvement. We identified 14 immune microenvironment types (IMTs) by integrating newly generated peripheral-blood scRNA-seq data with curated publicly available scRNA-seq datasets, and subsequently evaluated their spatial and clinical relevance using publicly available spatial and bulk transcriptomic datasets. The most clinically meaningful associations were observed in skin. These tissue states provide additional clinical resolution beyond serological subtype and disease duration and help explain variation in cutaneous severity.